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ABSTRACT
Regulation of protein synthesis is crucial for cells to maintain viability
and to prevent unscheduled proliferation that could lead to
tumorigenesis. Exposure to stress results in stalling of translation,
with many translation initiation factors, ribosomal subunits and
mRNAs being sequestered into stress granules or P bodies. This
allows the re-programming of the translation machinery. Many
aspects of translation are regulated by post-translational
modification. Several proteomic screens have identified translation
initiation factors as targets for sumoylation, although in many cases
the role of this modification has not been determined. We show here
that eIF4A2 is modified by SUMO, with sumoylation occurring on a
single residue (K226). We demonstrate that sumoylation of eIF4A2 is
modestly increased in response to arsenite and ionising radiation, but
decreases in response to heat shock or hippuristanol. In arsenite-
treated cells, but not in hippuristanol-treated cells, eIF4A2 is recruited
to stress granules, suggesting sumoylation of eIF4A2 correlates with
its recruitment to stress granules. Furthermore, we demonstrate that
the inability to sumoylate eIF4A2 results in impaired stress granule
formation, indicating a new role for sumoylation in the stress
response.
KEY WORDS: SUMO, Arsenite, Hippuristanol, Heat shock, Ionising
radiation, Translation, Protein synthesis
INTRODUCTION
Protein synthesis is a fundamental cellular process, which needs to
be efficiently regulated, particularly in response to environmental
stresses. It comprises three stages: initiation, elongation and
termination. Of these, the initiation step has a major regulatory
role in protein synthesis, and affects not only the level of protein
synthesis, but also which mRNAs are translated (Sonenberg and
Hinnebusch, 2009; Guertin and Sabatini, 2007; Laplante and
Sabatini, 2012; Morley et al., 2005; Jackson et al., 2010).
Translation initiation involves the binding of the preinitiation
complex [comprising the 40S ribosomal subunit, eukaryotic
initiation factor 3 (eIF3), eIF1A, eIF1, eIF5 and eIF2 (eIF2-GTP-
methionyl initiator tRNA)] to capped mRNA that is bound by eIF4F
(a complex of eIF4A, eIF4E and eIF4G). The resulting 48S
preinitiation complex then scans the 5′ untranslated region of the
mRNA for the initiation codon, at which point early initiation
factors are released and the large ribosomal subunit is recruited,
allowing protein synthesis to begin (reviewed in Jackson et al.,
2010).
In response to stress, most of the protein synthesis within a cell is
shut down in order to conserve energy to allow repair of stress-
induced damage and reprogramming of the translational machinery
(e.g. Spriggs et al., 2010; Balagopal and Parker, 2009). Polysomes
are disassembled, leading to the stalling of initiation complexes that
are then recruited to specialised bodies, termed stress granules.
These granules are proposed to be sites where, during stress and
recovery, individual mRNAs are sorted for storage, degradation or
translation. The granules are highly dynamic and can either fuse
with P bodies that contain the mRNA decay machinery, or can
release components to allow resumption of translation (Anderson
and Kedersha, 2009). Formation of stress granules is induced by
phosphorylation of eIF2α (Kedersha et al., 1999), or by other
factors, such as conditions that inhibit eIF4A (e.g. Dang et al.,
2006). Also important for induction are the T-cell internal antigen
(TIA) proteins, TIA-1 and TIA-R (also known as TIAL1), that have
prion-related C-terminal domains (Waris et al., 2014). In
mammalian cells, stress granules comprise numerous proteins
including eIF2, eIF3, eIF4A, eIF4E, eIF4G, poly(A)-binding
protein (PABP), the small ribosomal subunit and mRNAs (e.g.
Balagopal and Parker, 2009; Anderson et al., 2015). Depletion of
any one of a number of these proteins can lead to the formation of
stress granules (Mazroui et al., 2006; Mokas et al., 2009).
eIF4G is a large scaffold protein that possesses domains that
interact with eIF4E and eIF4A, to form the eIF4F complex, as well
as those that interact with eIF3 and PABP (Sonenberg and
Hinnebusch, 2009; Laplante and Sabatini, 2012; Morley et al.,
2005; Jackson et al., 2010). eIF4E is anmRNA-cap-binding protein,
and eIF4A proteins comprises a family of DEAD-box RNA
helicases, which are involved in many aspects of RNA metabolism.
In mammalian cells, there are three highly related eIF4A proteins,
eIF4A1, eIF4A2 and eIF4A3, which have diverse and non-
overlapping roles in mRNA metabolism (Lu et al., 2014). eIF4A3
is nuclear (Chan et al., 2004), whereas eIF4A1 and eIF4A2 are
cytoplasmic and, although functionally interchangeable in vitro, are
not functionally redundant in vivo (Nielsen and Trachsel, 1988;
Galicia-Vázquez et al., 2012; Yoder-Hill et al., 1993).Whereas both
eIF4A1 and eIF4A2 interact with eIF4G, eIF4A2, but not eIF4A1,
binds cNOT7 (Meijer et al., 2013). cNOT7 is a member of the
CCR4–NOT complex, that is required for deadenylation of mRNA,
and for microRNA (miRNA)-mediated gene regulation, indicating a
specific role for eIF4A2 in this process.
The interactions and functions of the proteins in the eIF4F
complex are regulated by a number of post-translational
modifications. For example, during normal protein synthesis, the
activity of eIF4F is regulated by eIF4E-binding proteins (4E-BPs)
(Matsuo et al., 1997). 4E-BPs bind to eIF4E and compete for the
interaction with eIF4G, thus inhibiting translation initiation. InReceived 10 December 2015; Accepted 29 April 2016
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mammalian cells, regulation of the interaction between 4E-BPs and
eIF4E occurs through the activation of the mechanistic target of
rapamycin complex 1 (mTORC1) that leads to the multi-site
phosphorylation of 4E-BP1 (reviewed in Sonenberg and
Hinnebusch, 2009). This prevents 4E-BP1 (also known as
EIF4EBP1) from binding to eIF4E, thereby allowing formation of
the eIF4F initiation complex and ribosomal recruitment of mRNA.
Another post-translational modification that regulates the
interaction of eIF4E with eIF4G is sumoylation of eIF4E by
SUMO1 (Xu et al., 2010).
SUMO is a small ubiquitin-like modifier that can be covalently
attached to target proteins (Hannoun et al., 2010). Modification by
SUMO affects protein–protein interactions, protein localisation and
protein activity, or can target proteins for ubiquitin-mediated
proteolysis (Enserink, 2015; Geiss-Friedlander and Melchior,
2007; Watts, 2004, 2007). In many cases, it acts by providing an
altered binding surface on the target protein. In mammalian cells
there are three SUMO proteins, SUMO1, SUMO2 and SUMO3.
SUMO2 and SUMO3 are 97% identical and are capable of forming
SUMO chains, whereas SUMO1 is less similar (50% identical) and
unable to form chains, but can act as a chain terminator (Matic et al.,
2008). SUMO is produced as a precursor protein, which is
processed to the mature form by one of a number of specific
proteases. It is then activated by interaction with the E1 SUMO-
activating enzyme (SAE; a complex of SAE1 and UBA2), from
where it is passed to an E2, SUMO-conjugating enzyme. From here,
it can be attached directly to target proteins, although in some cases
conjugation requires the activity of one of a small number of SUMO
ligases. Several proteomic screens have identified many of the
translation initiation factors as sumoylation targets (e.g. Matafora
et al., 2009; Bruderer et al., 2011; Blomster et al., 2009; reviewed in
Watts et al., 2014). However, in most cases, the effect of
sumoylation on individual target protein function remains to be
determined.
We have previously demonstrated that fission yeast and
mammalian eIF4G are sumoylated (Jongjitwimol et al., 2014),
and have identified two sumoylation sites in the C-terminus of
human eIF4G. Our initial studies suggest that sumoylation might
have a role in regulating protein synthesis in response to stress. To
further investigate this, we have analysed the effects of arsenite, heat
shock, hippuristanol and ionising radiation on the sumoylation of
members of the human eIF4F complex. We report here the
sumoylation of eIF4A in vivo by both SUMO1 and SUMO2, and
the identification of single sumoylation sites in eIF4A1 and eIF4A2.
We demonstrate that modification of eIF4A2 by SUMO1 is
increased in response to arsenite and ionising radiation but
decreased in response to heat shock and hippuristanol.
Furthermore, knocking down endogenous eIF4A2 and re-
transfection with an unsumoylatable version of eIF4A2 has a
detrimental effect on the formation of stress granules, indicating a
role for sumoylation of eIF4A2 in its localisation in stress granules.
Possible mechanisms whereby stress granule formation is affected
by this modification are discussed.
RESULTS
eIF4A is sumoylated in mammalian cells
The translation initiation factor eIF4F consists of three proteins:
eIF4A, eIF4E and eIF4G. We and others have previously
demonstrated that both mammalian eIF4E and eIF4G are
sumoylated (Xu et al., 2010; Jongjitwimol et al., 2014). We
therefore wished to determine whether eIF4A is also modified by
SUMO. To investigate this, we affinity-purified His-tagged SUMO
conjugates using Ni2+ agarose under denaturing conditions from
cell lines stably transfected with either His–SUMO1 or His–
SUMO2. Under these conditions, non-covalent interactions are
disrupted allowing the identification of post-translational
modifications. Western blots of affinity-purified proteins were
probed with antibody against SUMO1, an antibody recognising
both SUMO2 and SUMO3 (Fig. 1A) and antibody against eIF4A;
eIF4E and eIF4G were used as positive controls (Fig. 1B). Western
blotting with anti-eIF4G (Fig. 1Bi) identified a high molecular mass
species (>250 kDa) following affinity purification of both His–
SUMO1 and His–SUMO2 supporting our previous observation
(Jongjitwimol et al., 2014) showing that eIF4G is modified by
SUMO1 and, to a lesser extent, by SUMO2. Additionally, probing
with anti-eIF4E antisera (Fig. 1Bii) identified two minor species of
∼50 and 80 kDa and a more abundant species of ∼175 kDa
following purification of His–SUMO1 and His–SUMO2. Although
the predicted molecular mass of SUMO is 11 kDa, it migrates on
SDS-PAGE gels with an apparent molecular mass of 15–17 kDa.
Thus, the minor species (∼50 and ∼80 kDa) likely represent di- and
tri-sumoylated eIF4E, whereas the 175-kDa species corresponds to
poly-sumoylated eIF4E. [Although SUMO1 cannot be incorporated
into SUMO chains, it can act as a chain terminator (Ulrich, 2008).]
Fig. 1. eF4A, eIF4E and eIF4G are sumoylated in
mammalian cells.Whole-cell extracts (WCE) and
affinity purification on Ni2+ agarose under
denaturing conditions (AP) of His-tagged SUMO
from non-transfected HeLa cells (NT) and HeLa
cell lines stably transfected with His–SUMO1 (S1)
or His–SUMO2 (S2), analysed by SDS PAGE
(7.5%) and western blotted (IB) with anti-SUMO1
and anti-SUMO2/3 affinity-purified antibodies (A),
or anti-eIF4G, eIF4E and eIF4A antisera and
anti-eIF4A2 affinity-purified antibodies as indicated
(B). The position of molecular mass markers is
indicated.
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These modified forms are similar in size to the previously described
SUMO1-modified forms of eIF4E (Xu et al., 2010). As well as
being modified by SUMO1, the results in Fig. 1Bii indicate that
eIF4E is also modified by SUMO2. This would be consistent with
the presence of high molecular mass poly-SUMO chains that we
observe.
Having demonstrated that we are able to identify sumoylated
species using denaturing conditions, we probed similar blots with
anti-eIF4A antisera (Fig. 1Biii). Following affinity purification of
His–SUMO, we observed species migrating with an approximate
molecular mass of ∼70 and 150 kDa after purification of His–
SUMO1, and His–SUMO2. Given that the anti-eIF4A antisera
recognise both eIF4A1 and eIF4A2 proteins (Fig. S1), we repeated
the affinity purification and probed with anti-eIF4A2 affinity-
purified antibodies in order to determine whether this isoform of
eIF4A is sumoylated. In this case, a species of∼150 kDa is observed
with both His–SUMO1 and His–SUMO2 (Fig. 1Biv), likely
corresponding to the species of ∼150 kDa observed with anti-
eIF4A antisera. These results indicate that, like eIF4E and eIF4G,
eIF4A2 is sumoylated in vivo, and that it ismodified by both SUMO1
and SUMO2. The levels of sumoylation of these initiation factors are
typically in the region of 2–5% total eIF4A2 (similar to sumoylation
levels reported for other proteins, e.g. Johnson and Blobel, 1999).
Sumoylation of eIF4A2 is increased in response to arsenite
and ionising radiation
We have previously demonstrated that Schizosaccharomyces pombe
eIF4G is sumoylated in response to 1 M KCl (a condition that
induces stress granules in yeast) (Jongjitwimol et al., 2014). We
therefore investigated the effect of stress on sumoylation of eIF4G,
eIF4E or eIF4A2 in mammalian cells. We began by investigating
the effect of arsenite, which induces the formation of stress granules,
and ionising radiation, which causes genotoxic stress. Analysis of
global levels of sumoylation in response to arsenite (1 mM) and
ionising radiation (3 Gy) (Fig. S2A), indicated that exposure to
arsenite had a minimal effect on the levels of sumoylation by either
SUMO1 or SUMO2. In contrast, exposure to ionising radiation
reduced the level of global sumoylation by ∼50%. To analyse
sumoylation of the individual eIFs, His–SUMO1 and His–SUMO2
were affinity-purified from untreated cells and cells exposed to
arsenite or ionising radiation. Fig. 2A shows that sumoylation of
eIF4G by SUMO1 was somewhat reduced following exposure of
cells to arsenite. In contrast, sumoylation by SUMO1was reduced in
response to ionising radiation. In comparison to sumoylation by
SUMO1, only low levels of SUMO2-containing species were
observed. In the case of eIF4E, sumoylation by both SUMO1 and
SUMO2 increased in response to both arsenite and ionising
radiation (Fig. 2A). All four species seen represent sumoylated
forms of eIF4E; because the significance of the four different forms
is unknown, we have compared the levels of the total amount of
sumoylated species here.
We next investigated whether sumoylation of the eIF4A1 and
eIF4A2 isoforms was affected by stress. Analysis of the sumoylated
species of eIF4A1 indicated that only very low levels of sumoylated
eIF4A1 were observed under normal conditions, and that the levels
of these species were not altered in response to arsenite or ionising
radiation (Fig. 2A). In contrast, levels of sumoylated eIF4A2
increase in response to both stresses (Fig. 2A). This increased
sumoylation in response to arsenite and ionising radiation resembles
that of eIF4E suggesting that sumoylation of these two factors might
be coordinately regulated.
Sumoylation of proteins is known to affect protein localisation
(e.g. Muller et al., 1998; Finkbeiner et al., 2011). Given that
exposure of cells to arsenite results in the relocalisation of certain
translation initiation factors to stress granules (Kedersha et al.,
1999), we wished to determine whether sumoylation of eIF4A2 was
correlated with stress granule formation. We therefore compared the
effects of arsenite and ionising radiation on the localisation of
SUMO, eIF4G and eIF4A2. In untreated cells, the majority of the
SUMO was present in small nuclear speckles in the nucleus, with
low levels in the cytoplasm (Fig. 3). In cells treated with arsenite,
SUMO was relocalised to intra-nuclear foci, known as
promyelocytic leukaemia (PML) bodies, as has been
demonstrated previously (Muller et al., 1998), with low levels
remaining in the cytoplasm, whereas exposure to ionising radiation
resulted in small nuclear foci. In untreated cells, eIF4G and eIF4A2
were predominantly in the cytoplasm, but with a substantial
proportion in the nucleus (Fig. 3). Arsenite treatment resulted in the
relocalisation of both eIF4G and eIF4A2 into cytoplasmic granules.
Staining of arsenite-treated cells with antibodies against TIA-1, a
known stress granule marker (Kedersha et al., 1999), identified
these as stress granules (Fig. 4). In contrast to the effect of arsenite
Fig. 2. Exposure to arsenite and ionising
radiation affects sumoylation of eIF4G, eIF4E,
eIF4A1 and eIF4A2. Whole-cell extracts (WCE)
and affinity purification under denaturing conditions
as in Fig. 1 (AP) of His-tagged SUMO1 (S1) or
SUMO2 (S2) from stably transfected HeLa cell
lines or non-transfected cells (NT), untreated (UT)
or subjected to 1 mM arsenite (AR) for 30 min or
3 Gy ionising radiation (IR) with 30 min recovery,
analysed by SDS-PAGE (7.5%) and western
blotted. (A) Western blots probed with antisera
against eIF4G and eIF4E under conditions used in
Fig. 1B, as indicated, and with affinity-purified
antibodies against eIF4A1 and eIF4A2 as
indicated. (B) Whole-cell extracts (WCE) and
affinity purification (AP) as in Fig. 1A from cells that
were exposed to 1 mM arsenite, heat shocked at
42°C for 30 min (HS) or treated with 1 μM
hippuristanol (HP) for 60 min. Samples were
analysed by western blotting as in A.
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on eIF4A2 and eIF4G localisation, exposure to ionising radiation
had little effect on the localisation of eIF4G and eIF4A2 (Fig. 3).
Sumoylation of eIF4A2 is reduced following heat shock and
exposure to hippuristanol
We next extended our studies to analyse sumoylation of eIF4A2 in
response to two other stresses: heat shock and hippuristanol.
Hippuristanol is a small-molecule inhibitor of eIF4A1 and eIF4A2
that has previously been demonstrated to induce the formation of
eIF4A1-containing stress granules in an eIF2α-phosphorylation-
independent manner (Mazroui et al., 2006). Given that modification
of eIF4E and eIF4A2 by SUMO1 and SUMO2 appeared to be
similar, we focused here on sumoylation by SUMO1. Analysis of
global sumoylation levels of SUMO1-containing species indicated
that there was an increase in response to heat shock, but a slight
reduction in response to hippuristanol (Fig. S2B). As described
previously, His–SUMO1 was purified from cells under denaturing
conditions and western blots were probed with anti-eIF4A2
antibodies. Fig. 2B indicates that, in contrast to the increased
levels of sumoylation we observed with arsenite, sumoylation by
SUMO1 of eIF4A2 was reduced following exposure to heat shock
or hippuristanol.
As shown in Fig. 3, increased sumoylation of eIF4A2 correlated
with its relocalisation to stress granules. We therefore investigated
whether reduced sumoylation of eIF4A2, for example, as in the case
with hippuristanol, had any effect on this repositioning.
Furthermore, we wished to confirm that the aggregates we
observed were indeed stress granules. We therefore repeated the
immunofluorescence studies to compare the effects of arsenite, heat
shock, hippuristanol and ionising radiation using anti-eIF4A2
antibodies, along with anti-TIA-1 antibodies to identify stress
granules. Fig. 4 indicates that in response to arsenite, eIF4A2
colocalised with TIA-1, confirming the relocalisation of eIF4A2
into stress granules, an effect not observed with heat shock under
our assay conditions. As expected, exposure of cells to hippuristanol
resulted in the formation of stress granules; however, these did not
contain eIF4A2. This further supports the notion that sumoylation
of eIF4A2 correlates with its ability to form stress granules.
Identification of the sumoylation sites on eIF4A1 and eIF4A2
In order to identify the lysine residues used as SUMO-acceptor sites
on eIF4A1 and eIF4A2, we used an in vitro sumoylation assay
previously established in our laboratory (Ho et al., 2001).
Recombinant eIF4A1 and eIF4A2 were incubated with purified
sumoylation components, with a modified form of SUMO
containing a trypsin cleavage site adjacent to the diglycine motif
(Jongjitwimol et al., 2014), and products were analysed by liquid
chromatography tandem mass spectrometry (LC-MS/MS). In both
cases, a single lysine residue was identified: K225 and K226,
respectively (Fig. 5A). The eIF4A1 and eIF4A2 proteins are highly
conserved, as is the region containing the sumoylation sites
(Fig. 5B). This is not the case with eIF4A3, which does not have
a lysine residue at the equivalent position. Modelling of the
sumoylation sites onto the known crystal structures indicated that
the sites are in similar positions in the two proteins (Fig. 5C) on a
highly accessible surface of the protein in an α-helical domain.
These sites face the ATP-binding pocket (Oberer et al., 2005),
suggesting that sumoylation of eIF4A might affect its interaction
with ATP.
We have previously demonstrated that the C-terminus of
mammalian eIF4G is also sumoylated. Two sites were identified:
K1386 and K1588. These residues map to the eIF4A- and mitogen-
activated protein kinase (MAPK) interacting protein kinase 1
(Mnk1)-interacting regions of eIF4G (Fig. 5D). Molecular
modelling indicated that, interestingly, K1386 is close to Q1379
(Fig. 5E), which when mutated to lysine results in increased binding
of eIF4G to eIF4A (Bellsolell et al., 2006).
eIF4A2 is sumoylated on K226 in vivo
Given that eIF4A2 is more highly sumoylated in vivo than is eIF4A1
(Fig. 2A), we concentrated our studies on the eIF4A2 isoform,
focusing on SUMO1-containing species, as this would cover singly
Fig. 3. Exposure to arsenite affects the localisation of eIF4A2 and eIF4G.HeLa cells were cultured and treated as in Fig. 2, and were either treated with 1 mM
arsenite (AR) for 30 min or exposed to 3 Gy ionising radiation (IR) and allowed to recover for 30 min. Cells were then fixed and stained for SUMO1 and
either eIF4A2 or eIF4G. NT, non-transfected cells. (A) Immunofluorescence staining was performed using eIF4G and SUMO1. (B) eIF4A2 and SUMO1. Merged
images show DAPI (blue), eIF4A2 or eIF4G (red), and SUMO1 (green). Scale bars: 10 μm. We have observed at least 100 cells in each of three replicates
and clearly see that all cells exposed to arsenite contain stress granules.
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sumoylated species as well as those containing SUMO chains
terminating with SUMO1. Having shown that eIF4A2 is
sumoylated in vitro on K226, we wished to confirm that this
residue is used for sumoylation in vivo. To do this, expression of
endogenous eIF4A2 was knocked down using small interfering
RNA (siRNA), and cells were then transfected with wild-type (wt)
or mutant eIF4A2 (Fig. 6A). Despite the fact that the knockdown
was only partial (eIF4A2 is a very abundant protein making it
difficult to achieve 100% knockdown), introduction of siRNA-
resistant wild-type eIF4A2 into cells clearly results in new
high-molecular-mass species being observed following affinity-
purification of His-SUMO1 (lane 4). These species are of similar
molecular mass to those observed in Figs 1B and 2B, and are not
observed in the untransfected controls (lanes 1–3). In contrast,
although it is clear that the eIF4A2-K226 protein was expressed at
similar levels to the wt protein (lanes 4 and 5, lower panel), such
species were not observed when the eIF4A2-K226R mutant is
introduced (lane 5). This indicates that K226 is the main
sumoylation site in eIF4A2 that is used in vivo.
Inability to sumoylate eIF4A2 results in a reduction in stress
granule volume
To determine whether the inability to sumoylate eIF4A2 affects
either its recruitment to stress granules or the formation of the
granules, we used immunofluorescence with anti-FLAG antibodies
to compare the localisation of FLAG-tagged wt and FLAG–
eIF4A2-K226R protein expressed in cells as described above
(Fig. 6B). In unstressed cells, the localisation of the wt and mutant
proteins were very similar and resembled what we observed for
endogenous eIF4A2 (Fig. 3B). However, there was a distinct
difference in the localisation of the wt and mutant proteins in
response to arsenite. As observed with the endogenous protein,
FLAG-tagged eIF4A2 was observed in peri-nuclear stress granules,
indicating that the tag did not affect localisation. However,
recruitment of FLAG–eIF4A2-K226R to stress granules was
substantially less than that of the wt eIF4A2. To confirm the
identity of the granules, we repeated these experiments using anti-
TIA-1 antibodies in combination with anti-FLAG antibodies. In
arsenite-treated cells where eIF4A2 had been knocked down, there
was a substantial reduction in TIA-1-containing stress granules,
particularly in the number of large granules, compared to the
situation in mock-treated cells (Fig. 6C). Transfection with FLAG–
eIF4A2 wt restored the ability of cells to produce TIA-1-containing
granules in response to arsenite treatment. In cells transfected with
FLAG–eIF4A2-K226R, stress granules were also observed,
although there were generally fewer granules per cell. In particular
there was a substantial reduction in the number of large TIA-1-
containing stress granules (Fig. 6D), similar to the situation
observed in eIF4A2-knockdown cells. This reduction in large
TIA-1-containing stress granules correlated with the reduction in the
Fig. 4. eIF4A2 localises to arsenite-induced stress granules but not to hippuristanol-induced stress granules. HeLa cells were cultured and either left
untreated or subjected to the following treatments, 1 mM sodium arsenite (AR) for 30 min, heat-shock (HS) at 42°C for 30 min, 1 μM hippuristanol (HP) for
60 min or 3 Gy ionising radiation (IR) recovery for 30 min. The cells were fixed and immunostained for both eIF4A2 (as in Fig. 3) and TIA-1, followed by DAPI.
Merged images show TIA-1 (red), eIF4A2 (green) and DAPI (blue). Scale bars: 10 μm.
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number of large eIF4A2-containing granules. Furthermore, in cells
transfected with either wt or mutant eIF4A2, therewas a high degree
of colocalisation of eIF4A2 (both wt and mutant) with TIA-1
(Fig. 6E).
Despite the inability of eIF4A2 to be sumoylated, low levels of
SUMO were still detected in stress granules in cells expressing
FLAG–eIF4A2-K226R (Fig. 6B, bottom panels). This is likely to
be due to the fact that other components in stress granules are also
sumoylated, for example, eIF4G (Jongjitwimol et al., 2014; Bish
et al., 2015). These results indicate that it is the inability of eIF4A2
to be sumoylated, rather than the absence of SUMO that is causing
the defect in stress granule formation.
DISCUSSION
Stress granules have been characterised as cytoplasmic aggregates
that contain a number of proteins, including translation initiation
factors, ribosomal subunits, PABP and TIA proteins. Among the
translation initiation factors that are recruited to stress granules are
eIF4G and eIF4A, and more specifically eIF4A1 (Mazroui et al.,
2006). Here, we demonstrate that another isoform of eIF4A,
eIF4A2, which is functionally distinct from eIF4A1 (Lu et al.,
2014), can also be recruited to stress granules.
It has been well documented that post-translational modifications
are required for stress granule assembly (Buchan and Parker, 2009).
For example, a key event required for this process is
phosphorylation of eIF2α, and mutation of HDAC6, a histone
deacetylase that impairs stress granule formation (Kwon et al.,
2007), implicating acetylation as being involved. Additionally,
stress granules have been demonstrated to contain ubiquitin-
modified proteins (Kwon et al., 2007). Our studies here suggest
that sumoylation also has a role in protein recruitment to stress
granules. Specifically, we demonstrate that although arsenite and
hippuristanol both induce the formation of stress granules, only in
cells exposed to arsenite, which increases the level of sumoylation
of eIF4A2, is eIF4A2 recruited to stress granules. In contrast, in
hippuristanol-treated cells where sumoylation of eIF4A2 is
decreased, there is decreased recruitment of eIF4A2 to stress
granules. Unlike eIF4A2, eIF4A1 is recruited to stress granules in
response to hippuristanol (Mokas et al., 2009), further supporting
the view that the two proteins are functionally distinct (Lu et al.,
2014).
Using a combination of in vitro and in vivo studies, we have
demonstrated that eIF4A2 is sumoylated on K226. Mutation of this
site results in the impaired formation of TIA-1-containing stress
granules, as demonstrated by a decrease in overall stress granule
volume after treatment of cells with arsenite, thus indicating a role
for sumoylation in the formation of these granules. The sumoylation
site on eIF4A2 is on the same face as the ATP-binding site
suggesting that sumoylation might affect the interaction of eIF4A2
with ATP or its ATPase activity. It is known that ATP binding by
eIF4A causes a switch in the protein to a closed conformation that
allows ATP hydrolysis (Marintchev et al., 2009). This subsequently
facilitates the formation of an open conformation, resulting in
reduced affinity of eIF4A for mRNA. Thus, inability to sumoylate
eIF4A2might affect its interaction with mRNA, which in turn could
disrupt stress granule formation. Interestingly, hippuristanol, which
inhibits the recruitment of eIF4A2 to stress granules, is known to
interact with the eIF4A helicases at the ATP-binding site, and inhibit
the ATPase, RNA-binding and helicase activities of the protein
(Lindqvist et al., 2008). This supports the notion that sumoylation of
eIF4A2 might be affecting its interaction with ATP and/or RNA
binding.
Molecular modelling indicates that one of the sumoylation sites
in eIF4G that we have identified (K1386) maps to a region involved
in interacting with eIF4A (Fig. 5D). This further suggests that
sumoylation might regulate the interaction between eIF4G and
eIF4A. Indeed, mutation of a nearby residue (Q1379 to lysine)
results in increased binding of eIF4G to eIF4A (Bellsolell et al.,
Fig. 5. eIF4A1 and eIF4A2 are sumoylated on K225 and K226, respectively. (A) Mass spectra of sumoylation products. High-molecular-mass species from an
in vitro sumoylation assay were excised from SDS-PAGE gels and analysed by LC-MS/MS. (B) Sequence alignment of human eIF4A1, eIF4A2 and eIF4A3.
Sumoylation sites are indicated in red. (C) Position of sumoylation sites on eIF4A1 (i) and eIF4A2 (ii). Pymol-derived figure indicating sumoylation sites on human
eIF4A1 (PDB ID 2ZU6) and eIF4A2 (PDB ID 3BOR). ABP, ATP-binding pocket. (D) Schematic indicating organisation of interacting motifs in eIF4G. (E) Positions
of sumoylation site (K1386, green) and Q1379 (magenta) in the C-terminal fragment of eIF4G (PDB IB 1UG3).
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2006). Given that this lysine residue could potentially be targeted by
sumoylation, it would be interesting to determine whether the same
result is achieved by mutation to arginine (still a charge reversal
mutation, but to a residue which does not act as a SUMO acceptor).
As well as interacting with eIF4G, eIF4A2 interacts with
cNOT7, where it is likely involved in miRNA-mediated
translational repression. In collaboration with Lu and Bushell
(University of Leicester, Leicester, UK), we have observed
using overexpression constructs that mutation of the eIF4A2
sumoylation site (K226) has no effect on this process (Lu and
Bushell, personal communication). This would be consistent with
miRNA-mediated translational repression being a process used
under normal growth conditions, rather than a stress response, a
condition where we see increased sumoylation of eIF4A2.
Fig. 6. MutationofK226 results in lossof sumoylationof eIF4A2 in vivo anda reduction in stressgranule size. (A) His–SUMO1stably transfected cells were
reverse transfected with eIF4A2 siRNA (lanes 3–5). After 48 h, cells weremock treated (lane 2) or transfected with FLAG–myc–eIF4A2wt or FLAG–myc–eIF4A2-
K226R mutant as indicated. His-SUMO1 was purified from non-transfected cells (NT, lane 1) or His–SUMO1 stably transfected cells (S1, lanes 2–5) using Ni2+
agarose under denaturing conditions as in Figs 1 and 2. Proteins were analysed by SDS-PAGE and western blotted with anti-eIF4A2 antisera. (B) HeLa cells
were depleted of endogenous eIF4A2 and transfected with either FLAG–myc–eIF4A2 wt or FLAG–myc–eIF4A2-K226 and either left untreated (UT) or treated
with 1 mM arsenite (AR) for 30 min. Cells were immunostained with an anti-FLAG antibody and anti-SUMO. High-resolution images (lower panels) were
taken over a z-plane of 4 μm at 0.05 μm slices. Scale bars: 10 μm. (C) HeLa cells were prepared as in B and immunostained for FLAG (eIF4A2) and TIA-1.
Scale bars: 10 μm. (D) High-resolution z-stack images were taken and deconvolved using Huygens deconvolution software. Images were three-dimensionally
rendered using the IMARIS software suite. 3D images were used to calculate the volumes of stress granules for both TIA-1 and FLAG (eIF4A2). Box-and-whisker
plots were used to show the distribution of stress granule volumes. The box represents the 25–75th percentiles, and the median is indicated. The whiskers
show the 10–90th percentiles. n=2300 for TIA-1 and 800 for FLAG. (E) Cells processed as in C were analysed for colocalisation of FLAG and TIA-1
signals. The chart shows the percentage of FLAG (eIF4A2) signal that overlaps with TIA-1 in cells transfected with either FLAG-eIF4A2 WT or the K226R mutant
(mean±s.d., n=120).
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Identification of the effect(s) of sumoylation on individual
proteins has, in many cases proved problematic. For example, there
are a number of well-studied cases where several members of
multiprotein complexes are all sumoylated (Jentsch and Psakhye,
2013; Nie et al., 2015). In such cases, inability to sumoylate a single
member of the complex has little affect because sumoylation of
other components of the complex is sufficient for function. Thus,
although we have shown that sumoylation of eIF4A2 is required for
efficient formation of stress granules, it is possible, because this
protein is present in eIF4F complexes that contain eIF4G and eIF4E,
both of which are also sumoylated, that there might be further roles
for sumoylation of eIF4A2 still to be uncovered. However, now that
the sumoylation sites on the members of the eIF4F complex have
been identified, it should be possible to obtain a fuller understanding
of the role of sumoylation in regulating translation initiation.
MATERIALS AND METHODS
Protein expression and purification
Recombinant His–eIF4A1 and GST–eIF4A2 were prepared from E. coli
BL21 cells using Ni2+ agarose (Novagen) and glutathione–Sepharose,
respectively, according to the manufacturer’s instructions. Mammalian
whole-cell extracts (WCEs) were prepared from 5×105–106 mammalian
cells. Cells were washed once with PBS and then resuspended in 500 µl of
ice-cold 0.24 M NaOH and 1% (v/v) β-mercaptoethanol. The mixture was
incubated on ice for 15 min. 75 µl of 50% trichloroacetic acid (TCA) was
then added to the lysate that was further incubated on ice for 10 min.
Denatured proteins were precipitated by centrifugation at 13,000 g for
20 min at 4°C, and then resuspended in 30 µl of 1× SDS sample buffer. His-
tagged SUMO was affinity-purified from HeLa cells under denaturing
conditions using Ni2+ agarose as described previously (Jongjitwimol et al.,
2014). Western blotting was carried out as described previously (Harlow
and Lane, 1988).
Identification of sumoylation sites
The in vitro sumoylation assay was carried out as described elsewhere (Ho
et al., 2001). A modified form of SUMO containing a trypsin cleavable site
adjacent to the C-terminal diglycine motif, used for mass spectrometric
analysis, was as described previously (Jongjitwimol et al., 2014). Samples
were prepared for mass spectrometry using a modification of the method of
Shevchenko et al. (2006), as described previously (Jongjitwimol et al., 2014).
Molecular modelling
The positions of sumoylation sites on eIF4A and eIF4G crystal structures
were located using Pymol.
Tissue culture, cell lines and reagents
HeLa cells (supplied by ATCC, validated on 14May 2015 and demonstrated
to be mycoplasma-free on 27 May 2015) were cultured in DMEM
supplemented with 10% (v/v) fetal calf serum (FCS), penicillin,
streptomycin and L-glutamine. HeLa cells stably transfected with His-
tagged SUMO1 and SUMO2 were gifts from Ron Hay (University of
Dundee, Dundee, UK) (Girdwood et al., 2003; Vertegaal et al., 2004). For
analysis of stress responses, cells were treated with 1 mM sodium
arsenite for 30 min, 3 Gy ionising radiation from a 137Cs source and left
to recover for 30 min, heat shock at 42°C for 30 min or 1 μM hippuristanol
for 60 min.
siRNA depletion of eIF4A2 and siRNA-resistant expression of
eIF4A2
The K226R mutation was introduced into siRNA-resistant eIF4A2 by site-
directed mutagenesis using the QuickChange method (Stratagene). siRNA
(Silencer Select s4572) was from Life Technologies as described previously
(Meijer et al., 2013), and the siRNA-resistant FLAG-myc-eIF4A2 construct
was a gift from Martin Bushell (MRC Toxicology Unit, University of
Leicester, UK) (Meijer et al., 2013).
Antibodies
Antibodies used were as follows with dilutions in parentheses. Rabbit anti-
eIF4G (1:10,000), anti-eIF4E (1:3000) and anti-eIF4A (1:2000) were as
described previously (Coldwell et al., 2012; Morley and Pain, 1995). Mouse
monoclonal anti-eIF4G (sc-373892; 1:3000 for western blotting, 1:50 for
immunofluorescence), rabbit polyclonal anti-SUMO1 antibody (sc-9060;
1:2500 for western blotting, 1:50 for immunofluorescence), mouse
monoclonal anti-SUMO1 (sc-5308; 1:2500 for western blotting, 1:50 for
immunofluorescence), rabbit polyclonal antibody against both SUMO2 and
SUMO3 (sc-32873; 1:2500) were from Santa Cruz Biotechnology. Mouse
monoclonal anti-FLAG (F1804; 1:1000 for western blotting, 1:400 for
immunofluorescence) was from Sigma-Aldrich. Goat polyclonal anti-
eIF4A1 (sc-14211; 1:1000) and mouse anti-eIF4A2 (sc-137147; 1:200 for
immunofluorescence) were from Santa Cruz Biotechnology. Rabbit anti-
eIF4A2 (Ab194471; 1:3000) and rabbit anti-TIA-1 (Ab40693; 1:400) were
from Abcam. Secondary antibodies used were: horseradish peroxidase
(HRP)-conjugated goat anti-rabbit-IgG and rabbit anti-mouse-IgG (Dako),
both used at 1:2500 for western blotting, FITC-conjugated anti-mouse-IgG
and TritC-conjugated anti-rabbit-IgG (Sigma-Aldrich), Cy5-conjugated
anti-rabbit-IgG (Life Technologies) and TritC-conjugated anti-goat-IgG
(Santa Cruz Biotechnology) all used at 1:200.
Immunofluorescence
Cells cultured on coverslips were fixed using 4% (w/v) PFA in PBS for
10 min and permeabilised using 0.1% (v/v) Triton X-100 in PBS for 30 s.
Cells were washed three times with PBS before incubation for 1 h at room
temperature with the primary antibodies diluted to the indicated
concentration in 4% (w/v) BSA in PBS. Cells were washed a further three
times with PBS before incubation for 30 min with the secondary
fluorophore-coupled antibodies. Secondary antibodies were diluted as
above in 4% (w/v) BSA in PBS. Cells were washed a final three times before
mounting on glass slides with ProLong Gold with DAPI mounting medium
(Life Technologies). Cells were visualised using an Olympus IX70
microscope. Stress granules were analysed by taking deconvolved high-
resolution z-stack images over 4 µm at 0.05 µm intervals. Imaris software
suite was used to render three-dimensional images. Surface mapping was
used to create and calculate stress granule volumes.
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